|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500106013 |
|
最近更新日期: Date of Last Refreshed on: |
2025-07-15 17:53:36 |
|
注册时间: Date of Registration: |
2025-07-15 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
不同时序下重复经颅磁刺激联合运动训练对偏瘫患儿运动功能的临床疗效研究 |
|
Public title: |
Clinical efficacy of repeated transcranial magnetic stimulation combined with exercise training on motor function in children with hemiplegia in different time sequences |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
不同时序下重复经颅磁刺激联合运动训练对偏瘫患儿运动功能的临床疗效研究 |
|
Scientific title: |
Clinical efficacy of repeated transcranial magnetic stimulation combined with exercise training on motor function in children with hemiplegia in different time sequences |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
严婷婷 |
研究负责人: |
严婷婷 |
|
Applicant: |
Yan Tingting |
Study leader: |
Yan Tingting |
|
申请注册联系人电话: Applicant telephone: |
+86 791 8680 3576 |
研究负责人电话:
Study leader's |
+86 791 8680 3576 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
1252890015@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
1252890015@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
江西省南昌市阳明路122号 |
研究负责人通讯地址: |
江西省南昌市阳明路122号 |
|
Applicant address: |
No. 122, Yangming Road, Nanchang City, Jiangxi Province |
Study leader's address: |
No. 122, Yangming Road, Nanchang City, Jiangxi Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
江西省儿童医院 |
||
|
Applicant's institution: |
Jiangxi Provincial Children's Hospital |
||
|
研究负责人所在单位: |
江西省儿童医院 |
||
|
Affiliation of the Leader: |
Jiangxi Provincial Children's Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
JXSETYYYXKY--20240186-A1 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
江西省儿童医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Jiangxi Provincial Children's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-02-17 00:00:00 | ||
|
伦理委员会联系人: |
罗峻松 |
||
|
Contact Name of the ethic committee: |
Luo Junsong |
||
|
伦理委员会联系地址: |
江西省南昌市阳明路122号 |
||
|
Contact Address of the ethic committee: |
No. 122, Yangming Road, Nanchang City, Jiangxi Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 182 7083 1503 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
江西省儿童医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Jiangxi Provincial Children's Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
江西省南昌市阳明路122号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 122, Yangming Road, Nanchang City, Jiangxi Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-funded |
||||||||||||||||||||||
|
研究疾病: |
偏瘫 |
||||||||||||||||||||||
|
Target disease: |
Hemiplegia |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本研究将探索不同时序重复经颅磁联合运动训练的干预方法对偏瘫患儿运动功能的临床疗效,为偏瘫儿童运动功能障碍康复治疗提供临床依据。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study will explore the clinical efficacy of the intervention method of repetitive transcranial magnetic combined exercise training in different sequences on the motor function of children with hemiplegia, and provide a clinical basis for the rehabilitation treatment of motor dysfunction in children with hemiplegia. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.年龄为3-14岁; 2.有明显的外伤且经CT和(或)MRI检查证,或符合《 中国脑出血诊治指南(2019)》制定的脑出血性脑卒中或《中国急性缺血性脑卒中诊治(2020 版)》制定脑缺血性脑卒中诊断标准以及其他原因引起的脑损伤; 3.意识清醒且能主动配合训练; 4.首次发病; 5.存在一侧肢体运动功能障碍; 6.Brunnstrom分期Ⅲ ~ Ⅴ; 7.患儿及其家属对本研究内容均知情同意。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Age 3-14 years old; 2. Brain injury caused by obvious trauma and confirmed by CT and/or MRI examination, or in line with the "Chinese Guidelines for the Diagnosis and Treatment of Cerebral Hemorrhage (2019)" or the diagnostic criteria for cerebral ischemic stroke formulated by the "Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke (2020 Edition)" and other reasons; 3. Be conscious and able to actively cooperate with training; 4. First onset; 5. Presence of motor dysfunction of one limb; 6.Brunnstrom stage III. ~ V.; 7. The children and their families gave informed consent to the content of this study. |
||||||||||||||||||||||
|
排除标准: |
1.患有严重的心、肝、肾等重要脏器功能衰竭者; 2.病情危重且生命体征不稳定者; 3.活动性脑出血; 4.体内留置金属物者; 5.其它原因所致的意识障碍; 6.既往有癫痫病史或癫痫家族史。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Patients with severe heart, liver, kidney and other important organ failure; 2. Those who are critically ill and have unstable vital signs; 3. Active intracerebral hemorrhage; 4. Those who have metal objects in their bodies; 5. Impairment of consciousness caused by other reasons; 6. Previous history of epilepsy or family history of epilepsy. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-11-01 00:00:00至 To 2025-11-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-11-20 00:00:00 至 To 2025-11-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由同一个治疗师对入组患儿采取随机数字表法进行分组 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
By the same therapist, the children enrolled in the group are divided into groups using the random number table method |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
研究结束后,通过ResMan(www.medresman.org.cn)方式共享 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
After the end of the study, it was shared by ResMan (www.medresman.org.cn). |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
CRF;EDC |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF;EDC |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |